Browse studies

Find your next paid study

27,293 recruiting studies available now

Cannabidiol-Enhanced Cognitive Behavioral Therapy for Generalized Anxiety Disorder

This randomized, double-blind, placebo-controlled clinical trial investigates the use of Food and Drug Administration (FDA)-approved cannabidiol (EPIDIOLEX®) a…

Generalized Anxiety Disorder (GAD)Anxiety Disorders

Estimated

~$50 – $1,500

Actual pay is set by the research site.

Wayne State UniversityNCT07123467

Observational

Janus II: A Feasibility Study to Evaluate Response to Remede Dual Channel System Therapy

The objectives of this study are to evaluate the feasibility of the remedē® Dual Channel System at implant and overnight sleep studies and to assess chronic sa…

Sleep Apnea

Estimated

~$10 – $1,050

Actual pay is set by the research site.

Zoll Medical CorporationNCT06556693

Phase 2

A Phase 2/3 Multicenter, Open-label, Randomized, Active-Control Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (waveLINE-003)

The purpose of this Phase 2/3, randomized, multisite, open-label, dose confirmation, and expansion study is to evaluate the safety, and efficacy of zilovertama…

DLBCLDiffuse Large B-Cell Lymphoma

Estimated

~$75 – $2,800

Actual pay is set by the research site.

Merck Sharp & Dohme LLCNCT05139017

Phase 1

A Randomized, Double-Blind, Placebo-Controlled, Within-Subject Crossover Trial of a Single 4 mg Dose of Nicotine Polacrilex Gum on Auditory Oddball P3, Oddball Task Performance, and Resting-State EEG in Non-Smoking Adults With Chronic Tinnitus

This study tests whether a single dose of nicotine gum changes brain responses to sounds and the ability to detect target sounds in non-smoking adults with chr…

TinnitusChronic Subjective Tinnitus

Estimated

~$150 – $4,500

Actual pay is set by the research site.

Xianhui WangNCT07877701

Phase 4

Biometabolic Impact of Continuation of GLP-1 Agonists Following Bariatric

Glucagon-like peptide 1 (GLP-1) is a hormone that helps regulate blood glucose levels through improved insulin sensitivity and release of insulin from the panc…

Morbid ObesityMetabolic SyndromeDiabetes Mellitus+2 more

Estimated

~$25 – $1,000

Actual pay is set by the research site.

University of Missouri-ColumbiaNCT06132477

University of North Carolina Pleural Fluid Registry

Research with biospecimens such as blood, tissue, or body fluids can help researchers understand how the human body works. Researchers can make new tests to fi…

Lung CancerLung InfectionBreast Cancer+2 more

Estimated

~$10 – $750

Actual pay is set by the research site.

UNC Lineberger Comprehensive Cancer CenterNCT05620329

Phase 1

A Pilot Trial of Hematopoietic Stem Cell BCL11A Enhancer Gene Editing for Sickle Cell Disease

A promising approach for the treatment of genetic diseases is called gene therapy. Gene therapy is a relatively new field of medicine that uses genetic materia…

Sickle Cell DiseaseSickle Cell Anemia (HbSS, or HbSβ-thalassemia0)

Estimated

~$150 – $4,500

Actual pay is set by the research site.

Daniel BauerNCT07708350

Phase 2

A Phase 2 Study of Blinatumomab in Combination With Chemotherapy for Infants With Newly Diagnosed Acute Lymphoblastic Leukemia With Randomization of KMT2A-Rearranged Patients to Addition of Venetoclax

This phase II trial tests the addition of venetoclax and/or blinatumomab to usual chemotherapy for treating infants with newly diagnosed acute lymphoblastic le…

Acute Leukemia of Ambiguous LineageB Acute Lymphoblastic Leukemia

Estimated

~$75 – $1,800

Actual pay is set by the research site.

National Cancer Institute (NCI)NCT06317662

Phase 1

A Phase 1/2a, Multi-center, Open-label Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of PBGENE-DMD in Participants With Duchenne Muscular Dystrophy (FUNCTION-DMD)

The purpose of this Phase 1/2a trial is to evaluate the safety, tolerability, and preliminary efficacy of PBGENE-DMD in patients with DMD harboring mutations a…

Duchenne Muscular Dystrophy With Mutations Amenable to PBGENE-DMD

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Precision BioSciences, Inc.NCT07429240

Comprehensive Phenotyping of Type 1 Gaucher Disease Patients for Prodromal Parkinson's Disease: A Behavioral and Biomarker Study

Parkinson's disease (PD) is an age-related movement disorder with a complex pathophysiology. Among the risk factors for PD, variants in beta-glucocerebrosidase…

Parkinson Disease (PD)Type 1 Gaucher Disease

Estimated

~$10 – $750

Actual pay is set by the research site.

Icahn School of Medicine at Mount SinaiNCT07886879

Phase 2

Improving Balance and Mobility After Traumatic Brain Injury: A Randomized Controlled Trial Evaluating High Intensity Step Training

This study will explore whether the types and intensity of the interventions being delivered will yield measurable cognitive benefits in addition to improved m…

Traumatic Brain Injury

Estimated

~$75 – $2,000

Actual pay is set by the research site.

Craig HospitalNCT05702138

Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry

Continuation of the CARRA Registry as described in the protocol will support data collection on patients with pediatric-onset rheumatic diseases. The CARRA Reg…

Rheumatic Joint Disease

Estimated

~$10 – $750

Actual pay is set by the research site.

Duke UniversityNCT02418442